Effect of Pradaxa vs Warfarin on Bone Mass and Bone Turnover Markers

Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants

NCT03742336 ·Status: COMPLETED ·Phase: PHASE1

Edoxaban and Frailty in Senior Individuals

NCT03524924 ·Status: COMPLETED

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

NCT01662908 ·Status: COMPLETED ·Phase: PHASE2

Left Atrial Thrombus Reduction - Effect of Dabigatran Versus Phenprocoumon

NCT02591225 ·Status: UNKNOWN ·Phase: PHASE4

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)

NCT02072434 ·Status: COMPLETED ·Phase: PHASE3

A Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients.

NCT03715725 ·Status: TERMINATED

Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose

NCT02704052 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics

NCT01210755 ·Status: COMPLETED ·Phase: PHASE4

Patient Convenience Study

NCT02597920 ·Status: COMPLETED

Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..

NCT04297150 ·Status: UNKNOWN

A Trial of Rivaroxaban Versus Warfarin in Dissolving Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation

NCT03792152 ·Status: UNKNOWN ·Phase: NA

Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using Pradaxa

NCT02022020 ·Status: COMPLETED

Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for Acute Intermediate-Risk Pulmonary Embolism.

NCT02596555 ·Status: TERMINATED ·Phase: PHASE4

Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa

NCT02149303 ·Status: COMPLETED

Patient Convenience Study (RE-SONANCE)

NCT02684981 ·Status: COMPLETED

A Pilot Study on Edoxaban for the Resolution of Left Atrial Thrombosis in Patients With Non-valvular Atrial Fibrillation

NCT03489395 ·Status: COMPLETED ·Phase: PHASE2

The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)

NCT03129555 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism

NCT02132689 ·Status: COMPLETED ·Phase: PHASE4

The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients

NCT02646267 ·Status: UNKNOWN ·Phase: PHASE4

Warfarin - How Good Are we at Maintaining Target Range ?

NCT01081327 ·Status: COMPLETED

Predictors of Anticoagulation Control on Warfarin Therapy

NCT00905177 ·Status: COMPLETED

Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation

NCT03642509 ·Status: RECRUITING ·Phase: NA

Evaluating Medication Adherence to Novel Oral Anticoagulants With Anticoagulant Activity Monitoring in Patients With Atrial Fibrillation

NCT03666962 ·Status: UNKNOWN

Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery

NCT00846807 ·Status: COMPLETED

Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)

NCT02240667 ·Status: COMPLETED